HI
IART icon

Harbour Investments’s Integra LifeSciences IART Stock Holding History

Harbour Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59
Closed -$2.57K – 3270
2023
Q4 		$2.57K Buy
+59
New +$2.32K ﹤0.01% 2618
2021
Q3 		– Sell
-148
Closed -$10K – 3845
2021
Q2 		$10K Buy
148
+8
+6% +$566 ﹤0.01% 2728
2021
Q1 		$10K Buy
+140
New +$9.48K ﹤0.01% 2608

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Harbour Investments's IART Position: Q1 2024 in Review

Harbour Investments sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 59 shares — an estimated $2.57K sold.

Harbour Investments first reported a position in IART in Q1 2021 and held it in 3 quarters. The position peaked at $10K in Q2 2021. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Harbour Investments reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Harbour Investments sold 59 Integra LifeSciences shares in Q1 2024, an estimated $2.57K.
  • Harbour Investments first reported a position in Integra LifeSciences in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Integra LifeSciences position peaked at $10K in Q2 2021.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Harbour Investments's 13F filing for Q1 2024, filed 22 Jul 2024.